![]()
|
Report Date : |
05.03.2011 |
IDENTIFICATION DETAILS
|
Name : |
SABAA INTERNATIONAL CO FOR PHARMACEUTICALS & CHEMICALS INDUSTRIES |
|
|
|
|
Registered Office : |
Villa Al Maden Koliet Al Banat 6 |
|
|
|
|
Country : |
|
|
|
|
|
Year of Establishment : |
2000 |
|
|
|
|
Legal Form : |
Egyptian Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacture of pharmaceuticals |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 150,000 |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2010
|
Country Name |
Previous Rating (30.09.2010) |
Current Rating (31.12.2010) |
|
|
A2 |
A2 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SUMMARY
Company Name : SABAA INTERNATIONAL CO FOR PHARMACEUTICALS & CHEMICALS INDUSTRIES
Country of Origin :
Legal Form : Egyptian Joint Stock Company
Registration Date : 2000
Authorised Capital : £E 50,000,000
Issued Capital : £E 25,000,000
Paid up Capital : £E 25,000,000
Total Workforce : 35
Activities : Manufacture of pharmaceuticals
Financial Condition : Undetermined
Payments : Nothing detrimental uncovered
Recommended Credit Limit : US$ 150,000
SABAA INTERNATIONAL CO FOR PHARMACEUTICALS & CHEMICALS INDUSTRIES
Building : Villa Al
Maden Koliet Al
Street :
Area :
PO Box : 413
Town :
Country :
Telephone : (20-2) 24148529
Facsimile : (20-2)
22918390 / 24147619
Subject operates from a medium sized suite of offices that are rented
and located in the Central Business Area of Cairo.
Branch Office (s)
Location Description
· Baltiem Industrial
Zone Factory
premises
Dessouk
Kafr El
Sheikh
Tel:
(20-47) 2518772
Name Position
· El Sayed Abd El
Nabi Mohamed El Beilly Chairman
· Sahl Morsi Mohamed
Morsi El Damrawy Managing
Director
· Islam Abu El Maged IT
Manager
Date of
Establishment : 2000
Legal Form : Egyptian Joint
Stock Company
Authorised Capital : £E 50,000,000
Issued Capital : £E 25,000,000
Paid up Capital : £E 25,000,000
· El Sayed Abd El
Nabi Mohamed El Beilly
· Sahl Morsi Mohamed
Morsi El Damrawy
· Ali Aouf
· Abeer Ezzat Zahran
Activities: Engaged in the manufacture of pharmaceuticals, including catarrh
preparations, nerve tonics, depuratives, fish oil preparations and salt
tablets.
Import Countries:
Subject has a workforce of 35 employees.
Companies registered in
·
Banque du Caire SAE
19
Adly Street
Tel:
(20-2) 33926915
Fax:
(20-2) 33951713
No complaints regarding subject’s payments have been reported.
Local sources report that payment obligations are met in a generally
timely manner and the operating history is clear. As such the company is deemed
a fair trade risk and the above credit figure is considered to be within
subject’s financial means.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.99 |
|
|
1 |
Rs.73.24 |
|
Euro |
1 |
Rs.62.80 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.